Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Cytochrome P450 (CYP2C9) Genotype on Clinical Efficacy of Tenoxicam After Lower Third Molars Surgeries

NCT04182191 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT04182191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04182191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Cytochrome P450 (CYP2C9) Genotype on Clinical Efficacy of Tenoxicam After Lower Third Molars Surgeries
Lead sponsor
University of Sao Paulo
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2018
Completion date
November 1, 2019
Enrollment
89 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

molar, third, pain